1131615-01-4 Purity
96%
If you have any other questions or need other size, please get a quote.
Specification
Reference: [1]Current Patent Assignee: JOHNSON & JOHNSON INC - WO2022/53010, 2022, A1
Location in patent: Page/Page column 239; 242; 245
[2]Current Patent Assignee: FOGHORN THERAPEUTICS INC - WO2022/103899, 2022, A1
Location in patent: Page/Page column 201
[3]Current Patent Assignee: FOGHORN THERAPEUTICS INC - WO2022/103899, 2022, A1
Location in patent: Page/Page column 201
[4]Current Patent Assignee: FOGHORN THERAPEUTICS INC - WO2022/103899, 2022, A1
Location in patent: Page/Page column 201
Reference: [1]Current Patent Assignee: FORMA THERAPEUTICS HOLDINGS, INC - EP3636637, 2020, A1
Location in patent: Paragraph 0247-0250
* For details of the synthesis route, please refer to the original source to ensure accuracy.